Cargando…
SUN-414 Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: An Experience from a Tertiary Care Hospital
Tyrosine kinase inhibitors (TKI) belong to a new class of molecular multi-targeted anticancer therapy which targets different growth factor receptors and hence attenuates cancer cell survival and growth. TKI-induced thyroid dysfunction is recognized as a common adverse effect of treatment., but the...
Autores principales: | Wangnoo, Subhash Kumar, Siddiqui, Mohammad Asim, Pamnani, Harsha, Usman, Khwaja Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208000/ http://dx.doi.org/10.1210/jendso/bvaa046.1587 |
Ejemplares similares
-
SUN-485 Combined Treatment with Laser Ablation and Tyrosin Kinase Inhibitors. a Novel Multimodality Approach to Locally Advanced Thyroid Cancer?
por: Papini, Enrico, et al.
Publicado: (2020) -
SUN-624 Occurrence Of Papillary Thyroid Cancer During Treatment Of Thyroid Dysfunction
por: Ercan, Oya, et al.
Publicado: (2019) -
SUN-431 Case Finding Versus Routine Screening of Thyroid Dysfunction in Pregnancy
por: Al Qarni, Ali Ahmed, et al.
Publicado: (2020) -
SUN-503 Thyroid Storm Followed by ATD Induced Agranulocytosis in Late Pregnancy: A Management Dilemma
por: Aljehani, Faisal, et al.
Publicado: (2020) -
SUN-573 Plasmapheresis in Thyroid storm
por: Elmahboubi, Riham
Publicado: (2019)